المؤلفون: Chinatsu Nishida, Fuki Ujimiya, Hiroki Izumi, Kazuhiro Yatera, Kei Yamasaki, Koichi Goto, Moe Kidogawa, Shingo Matsumoto, Takanobu Jotatsu, Tatsuya Shingu, Tomoko Shiraishi

المصدر: Internal Medicine. 2023, 62(21):3215

المؤلفون: Tae Gen Son, Yoojin Seo, Won-Tae Kim, Meesun Kim, Seon Jeong Choi, Si Ho Choi, Byung-Jun Sung, Jae-Seok Min, Eon Chul Han, Hyung-Sik Kim

المصدر: International Journal of Molecular Sciences, Vol 25, Iss 7, p 3931 (2024)

مصطلحات موضوعية: three-dimensional (3D) culture, mesenchymal–epithelial transition (MET), regenerative potential, adipogenic differentiation, Biology (General), QH301-705.5, Chemistry, QD1-999

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/1422-0067/25/7/3931Test; https://doaj.org/toc/1661-6596Test; https://doaj.org/toc/1422-0067Test

الوصول الحر: https://doaj.org/article/45f4591041394a4294c1c68295d43f0dTest

المؤلفون: Kazuomi Ueshima, Masatoshi Kudo, Naoshi Nishida, Satoru Hagiwara, 上嶋 一臣, 工藤 正俊, 萩原 智, 西田 直生志

المصدر: 肝臓 / Kanzo. 2023, 64(10):514

المؤلفون: Paras Jain (199642), Sophia Corbo (14317900), Kulsoom Mohammad (14317903), Sarthak Sahoo (9434542), Santhalakshmi Ranganathan (817086), Jason T. George (6252491), Herbert Levine (14317906), Joseph Taube (4458358), Michael Toneff (14317909), Mohit Kumar Jolly (566038)

مصطلحات موضوعية: Systems Biology, epithelial–mesenchymal plasticity, mathematical modelling, chromatin-mediated epigenetic regulation, mesenchymal–epithelial transition (MET), epigenetic memory

العلاقة: https://figshare.com/articles/journal_contribution/Supplementary_figures_from_Epigenetic_memory_acquired_during_long-term_EMT_induction_governs_the_recovery_to_the_epithelial_state/21804511Test

الإتاحة: https://doi.org/10.6084/m9.figshare.21804511.v1Test

المؤلفون: Calogera Claudia Spagnolo, Giuliana Ciappina, Elisa Giovannetti, Andrea Squeri, Barbara Granata, Chiara Lazzari, Giulia Pretelli, Giulia Pasello, Mariacarmela Santarpia

المصدر: International Journal of Molecular Sciences; Volume 24; Issue 12; Pages: 10119

مصطلحات موضوعية: non-small cell lung cancer (NSCLC), mesenchymal-epithelial transition (MET), targeted therapy, oncogene, predictive biomarkers, tyrosine kinase inhibitors (TKIs)

جغرافية الموضوع: agris

وصف الملف: application/pdf

العلاقة: Molecular Oncology; https://dx.doi.org/10.3390/ijms241210119Test

الإتاحة: https://doi.org/10.3390/ijms241210119Test

المؤلفون: Lili Liang, Andreas M. Kaufmann

المصدر: International Journal of Molecular Sciences; Volume 24; Issue 3; Pages: 2555

مصطلحات موضوعية: tumor initiating cells, stemness, epithelial–mesenchymal transition (EMT), hybrid EMT, partial EMT, mesenchymal–epithelial transition (MET), tumor microenvironment (TME), invasion

جغرافية الموضوع: agris

وصف الملف: application/pdf

العلاقة: Molecular Oncology; https://dx.doi.org/10.3390/ijms24032555Test

الإتاحة: https://doi.org/10.3390/ijms24032555Test

المؤلفون: Jeffrey D. Amack

المصدر: Cell Communication and Signaling, Vol 19, Iss 1, Pp 1-16 (2021)

مصطلحات موضوعية: Epithelial-mesenchymal transition (EMT), Mesenchymal-epithelial transition (MET), Cell migration, Cancer metastasis, Actin cytoskeleton, In vivo live imaging, Medicine, Cytology, QH573-671

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1478-811XTest

الوصول الحر: https://doaj.org/article/7dd39b6ca52e4b8cac1415d8a0bdf58aTest

المؤلفون: Sandhya Sriram, Nam-Young Kang, Subha Subramanian, Tannistha Nandi, Samydurai Sudhagar, Qiaorui Xing, Gerine Jin-Ling Tong, Allen Kuan-Liang Chen, Thekkeparambil Chandrabose Srijaya, Patrick Tan, Yuin-Han Loh, Young-Tae Chang, Shigeki Sugii

المصدر: Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-15 (2021)

مصطلحات موضوعية: DOFLA library fluorescence dye, Human induced pluripotent stem cell (hiPSC), Early stage pluripotency, Mesenchymal-epithelial transition (MET), Adipose-derived stromal cell (ASC), Dental pulp stem cell (DPSC), Medicine (General), R5-920, Biochemistry, QD415-436

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1757-6512Test

الوصول الحر: https://doaj.org/article/dc124a60d6274e229a1bcfaadff85571Test

المؤلفون: D. I. Vodolazhsky, T. L. Nekhaeva, I. A. Baldueva, Д. И. Водолажский, Т. Л. Нехаева, И. А. Балдуева

المصدر: Siberian journal of oncology; Том 21, № 3 (2022); 117-125 ; Сибирский онкологический журнал; Том 21, № 3 (2022); 117-125 ; 2312-3168 ; 1814-4861 ; 10.21294/1814-4861-2022-21-3

مصطلحات موضوعية: мезенхимально-эпителиальный переход (МЭП), malignant neoplasms, malignancy markers, extracellular DNA (cfDNA), epithelial-mesenchymal transition (EMT), mesenchymal-epithelial transition (MET), злокачественные новообразования, маркеры малигнизации, внеклеточная ДНк (вкДНк), эпителиально-мезенхимальный переход (ЭМП)

وصف الملف: application/pdf

العلاقة: https://www.siboncoj.ru/jour/article/view/2169/994Test; Chaffer C.L., Weinberg R.A. A perspective on cancer cell metastasis. Science. 2011; 331(6024): 1559–64. doi:10.1126/science.1203543.; Di Raimo T., De Santis E., Coppola L., D’Andrea M.R., Angelini F. Circulating tumor cells and the metastatic process: the complexity of malignancy. J Cancer Metastasis Treat. 2018; 4: 54. Open Access Review. doi 10.20517/2394-4722.2018.50.; Ashworth T.R. A Case of Cancer in Which Cells Similar to Those in the Tumours Were Seen in the Blood after Death. The Medical Journal of Australia. 14: 146–7.; Messerschmidt J.L., Bhattacharya P., Messerschmidt G.L. Cancer Clonal Theory, Immune Escape, and Their Evolving Roles in Cancer Multi-Agent Therapeutics. Curr Oncol Rep. 2017; 19(10): 66. doi:10.1007/ s11912-017-0625-2.; Agnoletto C., Corrà F., Minotti L., Baldassari F., Crudele F., Cook W.J.J., Di Leva G., d’Adamo A.P., Gasparini P., Volinia S. Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset. Cancers (Basel). 2019; 11(4): 483. doi:10.3390/cancers11040483.; Corporate Medical Policy. An Independent Licensee of the Blue Cross and Blue Shield Association. Detection of Circulating Tumor Cells and Cell Free DNA in Cancer Management AHS-G2054 [Internet]. 2019. URL: https://www.bluecrossnc.com/sites/default/fles/document/attachment/services/public/pdfs/medicalpolicy/detectionTest of circulating tumor cells and cell free dna in cancer management 4.pdf.; Kang H.M., Kim G.H., Jeon H.K., Kim D.H., Jeon T.Y., Park D.Y., Jeong H., Chun W.J., Kim M.H., Park J., Lim M., Kim T.H., Cho Y.K. Circulating tumor cells detected by lab-on-a-disc: Role in early diagnosis of gastric cancer. PLoS One. 2017; 12(6). doi:10.1371/journal.pone.0180251.; Miller M.C., Doyle G.V., Terstappen L.W. Signifcance of Circulating Tumor Cells Detected by the Cell Search System in Patients with Metastatic Breast Colorectal and Prostate Cancer. J Oncol. 2010. doi:10.1155/2010/617421.; Kaldjian E.P., Ramirez A.B., Sun Y., Campton D.E., Werbin J.L., Varshavskaya P., Quarre S., George T., Madan A., Blau C.A., Seubert R. The RareCyte® platform for next-generation analysis of circulating tumor cells. Cytometry A. 2018; 93(12): 1220–5. doi:10.1002/cyto.a.23619.; Ferreira M.M., Ramani V.C., Jeffrey S.S. Circulating tumor cell technologies. Mol Oncol. 2016; 10(3): 374–94. doi:10.1016/j. molonc.2016.01.007.; Grover P.K., Cummins A.G., Price T.J., Roberts-Thomson I.C., Hardingham J.E. Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research. Ann Oncol. 2014; 25(8): 1506–16. doi:10.1093/annonc/mdu018.; Murray N.P., Reyes E., Badínez L., Orellana N., Fuentealba C., Olivares R., Porcell J., Dueñas R. Circulating Prostate Cells Found in Men with Benign Prostate Disease Are P504S Negative: Clinical Implications. J Oncol. 2013. doi:10.1155/2013/165014.; Karabacak N.M., Spuhler P.S., Fachin F., Lim E.J., Pai V., Ozkumur E., Martel J.M., Kojic N., Smith K., Chen P.I., Yang J., Hwang H., Morgan B., Trautwein J., Barber T.A., Stott S.L., Maheswaran S., Kapur R., Haber D.A., Toner M. Microfuidic, marker-free isolation of circulating tumor cells from blood samples. Nat. Protoc. 2014; 9(3): 694–710. doi:10.1038/nprot.2014.044.; Mitra A., Mishra L., Li S. EMT, CTCs and CSCs in tumor relapse and drug-resistance. Oncotarget. 2015; 6(13): 10697–711. doi:10.18632/ oncotarget.4037.; Vishnoi M., Peddibhotla S., Yin W., T. Scamardo A., George G.C., Hong D.S., Marchetti D. The isolation and characterization of CTC subsets related to breast cancer dormancy. Sci Rep. 2015; 5: 17533. doi:10.1038/srep17533.; Reinhardt F., Franken A., Meier-Stiegen F., Driemel C., Stoecklein N.H., Fischer J.C., Niederacher D., Ruckhaeberle E., Fehm T., Neubauer H. Diagnostic Leukapheresis Enables Reliable Transcriptomic Profling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine Resistance. Cancers (Basel). 2019; 11(7): 903. doi:10.3390/cancers11070903.; Broncy L., Paterlini-Bréchot P. Clinical Impact of Circulating Tumor Cells in Patients with Localized Prostate Cancer. Cells. 2019; 8(7): 676. doi:10.3390/cells8070676.; Marchetti A., Del Grammastro M., Felicioni L., Malatesta S., Filice G., Centi I., De Pas T., Santoro A., Chella A., Brandes A.A., Venturino P., Cuccurullo F., Crinò L., Buttitta F. Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatment. PLoS One. 2014; 9(8). doi:10.1371/journal.pone.0103883.; Ellsworth R.E., Blackburn H.L., Shriver C.D., Soon-Shiong P., Ellsworth D.L. Molecular heterogeneity in breast cancer: State of the science and implications for patient care. Semin Cell Dev Biol. 2017; 64: 65–72. doi:10.1016/j.semcdb.2016.08.025.; Wang Y., Waters J., Leung M.L., Unruh A., Roh W., Shi X., Chen K., Scheet P., Vattathil S., Liang H., Multani A., Zhang H., Zhao R., Michor F., Meric-Bernstam F., Navin N.E. Clonal evolution in breast cancer revealed by single nucleus genome sequencing. Nature. 2014; 512(7513): 155–60. doi:10.1038/nature13600.; Williams M.J., Sottoriva A., Graham T.A. Measuring Clonal Evolution in Cancer with Genomics. Annu Rev Genomics Hum Genet. 2019; 20: 309–29. doi:10.1146/annurev-genom-083117-021712.; Francart M.E., Lambert J., Vanwynsberghe A.M., Thompson E.W., Bourcy M., Polette M., Gilles C. Epithelial-mesenchymal plasticity and circulating tumor cells: Travel companions to metastases. Dev Dyn. 2018; 247(3): 432–50. doi:10.1002/dvdy.24506.; Pastushenko I., Blanpain C. EMT Transition States during Tumor Progression and Metastasis. Trends Cell Biol. 2019; 29(3): 212–26. doi:10.1016/j.tcb.2018.12.001.; Werner S., Stenzl A., Pantel K., Todenhöfer T. Expression of Epithelial Mesenchymal Transition and Cancer Stem Cell Markers in Circulating Tumor Cells. Adv Exp Med Biol. 2017; 994: 205–28. doi:10.1007/978-3-319-55947-6_11.; Veridex L.L.C. CellSearch TM. Circulating Tumor Cell Kit. Premarket Notifcation- Expanded Indications for Use Metastatic Prostate Cancer [Internet]. URL: https://www.accessdata.fda.gov/cdrh_docs/pdf7Test/ K073338.pdf.; Cabel L., Proudhon C., Gortais H., Loirat D., Coussy F., Pierga J.Y., Bidard F.C. Circulating tumor cells: clinical validity and utility. Int J Clin Oncol. 2017; 22(3): 421–30. doi:10.1007/s10147-017-1105-2.; Kallergi G., Politaki E., Alkahtani S., Stournaras C., Georgoulias V. Evaluation of Isolation Methods for Circulating Tumor Cells (CTCs). Cell Physiol Biochem. 2016; 40(3–4): 411–9. doi:10.1159/000452556.; Cristofanilli M., Budd G.T., Ellis M.J., Stopeck A., Matera J., Miller M.C., Reuben J.M., Doyle G.V., Allard W.J., Terstappen L.W., Hayes D.F. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004; 351(8): 781–91. doi:10.1056/NEJMoa040766.; Negin B.P., Cohen S.J. Circulating tumor cells in colorectal cancer: past, present, and future challenges. Curr Treat Options Oncol. 2010; 11(1–2): 1–13. doi:10.1007/s11864-010-0115-3.; Resel Folkersma L., Olivier Gómez C., San José Manso L., Veganzones de Castro S., Galante Romo I., Vidaurreta Lázaro M., de la Orden G.V., Arroyo Fernández M., Díaz Rubio E., Silmi Moyano A., Maestro de Las Casas M.A. Immunomagnetic quantifcation of circulating tumoral cells in patients with prostate cancer: clinical and pathological correlation. Arch Esp Urol. 2010; 63(1): 23–31.; Riethdorf S., Pantel K. Advancing personalized cancer therapy by detection and characterization of circulating carcinoma cells. Ann N Y Acad Sci. 2010; 1210: 66–77. doi:10.1111/j.1749-6632.2010.05779.x.; Aggarwal C., Meropol N.J., Punt C.J., Iannotti N., Saidman B.H., Sabbath K.D., Gabrail N.Y., Picus J., Morse M.A., Mitchell E., Miller M.C., Cohen S.J. Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer. Ann Oncol. 2013; 24(2): 420–8. doi:10.1093/annonc/mds336.; Кит О.И., Нистратова О.В., Новикова И.А., Водолажский Д.И., Никипелова Е.А., Непомнящая Е.М., Ульянова Е.П., Олейникова Е.Н. Ассоциация между наличием KRAS-мутаций в опухоли и количеством циркулирующих опухолевых клеток у больных колоректальным раком. Кубанский научный медицинский вестник. 2016; 1(156): 70–3. [Kit O.I., Nistratova O.V., Novikova I.A., Vodolazhsky D.I., Nikipelova E.A., Nepomnyashchaya E.M., Ulyanova E.P., Oleinikova E.N. The association between the presence of KRAS mutations in the tumor and the number of circulating tumor cells in patients with colorectal cancer. Kuban Scientifc Medical Bulletin. 2016; 1(156): 70–3. (in Russian)].; To expand the indication for use of the CellSearch™ CTC Assay for use with colon cancer as well as the previously cleared breast cancer [Internet]. URL: www.accessdata. Fda.gov/cdrh_docs/reviews/K071729.; Allard W.J., Matera J., Miller M.C., Repollet M., Connelly M.C., Rao C., Tibbe A.G., Uhr J.W., Terstappen L.W. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res. 2004; 10(20): 6897–904. doi:10.1158/1078-0432.CCR-04-0378.; Farace F., Massard C., Vimond N., Drusch F., Jacques N., Billiot F., Laplanche A., Chauchereau A., Lacroix L., Planchard D., Le Moulec S., André F., Fizazi K., Soria J.C., Vielh P. A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas. Br J Cancer. 2011; 105(6): 847–53. doi:10.1038/bjc.2011.294.; Tamminga M., Andree K.C., Hiltermann T.J.N., Jayat M., Schuuring E., van den Bos H., Spierings D.C.J., Lansdorp P.M., Timens W., Terstappen L.W.M.M., Groen H.J.M. Detection of Circulating Tumor Cells in the Diagnostic Leukapheresis Product of Non-Small-Cell Lung Cancer Patients Comparing CellSearch® and ISET. Cancers (Basel). 2020; 12(4): 896. doi:10.3390/cancers12040896.; Campton D.E., Ramirez A.B., Nordberg J.J., Drovetto N., Clein A.C., Varshavskaya P., Friemel B.H., Quarre S., Breman A., Dorschner M., Blau S., Blau C.A., Sabath D.E., Stilwell J.L., Kaldjian E.P. High-recovery visual identifcation and single-cell retrieval of circulating tumor cells for genomic analysis using a dual-technology platform integrated with automated immunofuorescence staining. BMC Cancer. 2015; 15: 360. doi:10.1186/s12885-015-1383-x.; Werbin J.L., Nordberg J.J., Tzucker J., Varshavskaya P., Stilwell J.L., Kaldjian E.P. RareCyte® CTC Analysis Step 2: Detection of Circulating Tumor Cells by CyteFinder® Automated Scanning and Semiautomated Image Analysis. Methods Mol Biol. 2017; 1634: 173–80. doi:10.1007/978- 1-4939-7144-2_14.; Blau C.A., Ramirez A.B., Blau S., Pritchard C.C., Dorschner M.O., Schmechel S.C., Martins T.J., Mahen E.M., Burton K.A., Komashko V.M., Radenbaugh A.J., Dougherty K., Thomas A., Miller C.P., Annis J., Fromm J.R., Song C., Chang E., Howard K., Austin S., Schmidt R.A., Linenberger M.L., Becker P.S., Senecal F.M., Mecham B.H., Lee S.I., Madan A., Ronen R., Dutkowski J., Heimfeld S., Wood B.L., Stilwell J.L., Kaldjian E.P., Haussler D., Zhu J. A Distributed Network for Intensive Longitudinal Monitoring in Metastatic Triple-Negative Breast Cancer. J Natl Compr Canc Netw. 2016; 14(1): 8–17. doi:10.6004/jnccn.2016.0003.; Chalfn H.J., Glavaris S.A., Gorin M.A., Kates M.R., Fong M.H., Dong L., Matoso A., Bivalacqua T.J., Johnson M.H., Pienta K.J., Hahn N.M., McConkey D.J. Circulating Tumor Cell and Circulating Tumor DNA Assays Reveal Complementary Information for Patients with Metastatic Urothelial Cancer. Eur Urol Oncol. 2021; 4(2): 310–4. doi:10.1016/j. euo.2019.08.004.; Chou W.C., Wu M.H., Chang P.H., Hsu H.C., Chang G.J., Huang W.K., Wu C.E., Hsieh J.C. A Prognostic Model Based on Circulating Tumour Cells is Useful for Identifying the Poorest Survival Outcome in Patients with Metastatic Colorectal Cancer. Int J Biol Sci. 2018; 14(2): 137–46. doi:10.7150/ijbs.23182.; Boral D., Vishnoi M., Liu H.N., Yin W., Sprouse M.L., Scamardo A., Hong D.S., Tan T.Z., Thiery J.P., Chang J.C., Marchetti D. Molecular characterization of breast cancer CTCs associated with brain metastasis. Nat Commun. 2017; 8(1): 196. doi:10.1038/s41467-017-00196-1.; https://www.siboncoj.ru/jour/article/view/2169Test

الإتاحة: https://doi.org/10.21294/1814-4861-2022-21-3-117-125Test
https://doi.org/10.21294/1814-4861-2022-21-3Test
https://doi.org/10.1126/science.1203543Test
https://doi.org/10.3390/cancers11040483Test
https://doi.org/10.1371/journal.pone.0180251Test
https://doi.org/10.1155/2010/617421Test
https://doi.org/10.1002/cyto.a.23619Test
https://doi.org/10.1016/jTest
https://doi.org/10.1093/annonc/mdu018Test
https://doi.org/10.1155/2013/165014Test

المؤلفون: Shabnam Rehman, Grace K. Dy

المصدر: European Medical Journal, Vol 4, Iss 1, Pp 100-111 (2019)

مصطلحات موضوعية: hepatocyte growth factor (hgf), mesenchymal–epithelial transition (met), met inhibitors, non-small cell lung cancer (nsclc), Medicine

وصف الملف: electronic resource

العلاقة: https://www.emjreviews.com/oncology/articleTest/met-inhibition-in-non-small-cell-lung-cancer/; https://doaj.org/toc/2397-6764Test

الوصول الحر: https://doaj.org/article/e7ef6bc306d44eec9f5c055640a53b41Test